News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York, May 10, 2025 (GLOBE NEWSWIRE) - ...
After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...
Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months. It’s a tough time to compete with new weight-loss drugs ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...